Immune Globulins: Therapeutic, Pharmaceutical, Cost, and Administration Considerations
Jerry Siegel, PharmD, FASHP
by Jerry Siegel, PHARMD, FASHP
For the past several years, the availability of immune globulin (Ig)
products has been very good, so product shortages have not played a
major role in product choice. This allows clinicians to match the best
product to the patient based on clinical condition and comorbidities.
New products have become available, providing more treatment options.
This flip chart provides an overview of currently available Ig products
along with information about their sterility, stability, and clinical